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In the development of RNA interference therapeutics, merely selecting
short interfering RNA (siRNA) sequences that are complementary to the
mRNA target does not guarantee target silencing. Current algorithms for
selecting siRNAs rely on many parameters, one of which is asymmetry,
often predicted through calculation of the relative thermodynamic stabili-
ties of the two ends of the siRNA. However, we have previously shown
that highly active siRNA sequences are likely to have particular nucleotides
at each 5′-end, independently of their thermodynamic asymmetry. Here, we
describe an algorithm for predicting highly active siRNA sequences based
only on these two asymmetry parameters. The algorithm uses end-sequence
nucleotide preferences and predicted thermodynamic stabilities, each
weighted on the basis of training data from the literature, to rank the
probability that an siRNA sequence will have high or low activity. The
algorithm successfully predicts weakly and highly active sequences for
enhanced green fluorescent protein and protein kinase R. Use of these two
parameters in combination improves the prediction of siRNA activity over
current approaches for predicting asymmetry. Going forward, we anticipate
that this approach to siRNA asymmetry prediction will be incorporated
into the next generation of siRNA selection algorithms.
Introduction
Therapeutic applications of RNA interference
(RNAi) make use of a conserved pathway for gene
expression regulation that possesses the potential for
exquisite sequence specificity through the complemen-
tarity of short interfering RNAs (siRNAs) for their
targets [1–3]. Although the technology has yet to
demonstrate its full potential in clinical applications
[4,5], there remains major interest in developing
siRNA-based therapeutics [6]. Because RNAi repre-
sents a therapeutic approach that can be applied to
nearly any disease [7,8], improvements in the design
and development of siRNA therapeutics have the
potential to have a significant impact on clinical
practice.
A number of intermolecular interactions are critical
to the activity of siRNAs, including those with the
delivery vehicle [9–11], the target mRNA [12–15], and
the pathway proteins [16–19]. Whereas a single RNA
guide strand and argonaute 2 are the minimal compo-
nents required for active silencing in vitro [20], the pro-
teins Dicer and TAR RNA-binding protein are
important for RNA-induced silencing complex (RISC)
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loading complex/RISC activity in vivo [21–23]. Other
proteins, such as the protein activator of dsRNA-
dependent protein kinase R (PKR) [24,25] and
component 3 promoter of RISC [26], may also have
important but as yet undefined functional roles in the
RNAi process. One essential process executed by the
pathway proteins is the identification and loading of
the siRNA guide strand into RISC loading complex/
RISC and the concomitant destruction of the passen-
ger strand [2,27,28]. The likelihood of one siRNA
strand becoming the guide strand relative to the other
strand is termed asymmetry [27,29].
There are currently multiple proteins that are
thought to participate in sensing the asymmetry of
siRNA duplexes [18,30–32]. When the existence of
siRNA asymmetry was first established, it was pro-
posed that the relative hybridization stabilities of the
two ends of the siRNA sequence constituted the prin-
cipal means by which asymmetry was sensed by the
pathway proteins [29]. Since that time, nearly all algo-
rithms for selecting highly active siRNAs have used a
thermodynamic calculation for asymmetry, among
other parameters [29,33–37]. More recently, evidence
has begun to accumulate that the terminal nucleotides
on each 5′-end of the siRNA may be valuable for
predicting the activity of an siRNA [18,30,38], in
particular when classified according to the 16 possible
combinations of nucleotides. When terminal nucleo-
tide classification is combined with relative hybridiza-
tion stability, the accuracy of predicting siRNA
activity improves markedly [38].
In this study, we wanted to predict siRNA activities
on the basis of only two asymmetry characteristics,
terminal nucleotide classification and relative thermo-
dynamic stability (Fig. 1), and establish experimentally
their relative importance in determining the activity of
an siRNA. Using a logistic regression model, we suc-
cessfully predicted active and inactive sequences for
the exogenous protein enhanced green fluorescent
protein (EGFP) and the endogenous protein PKR. In
addition, the combination of both end-sequence and
thermodynamic stability features provided improved
correlation with siRNA activity as compared with
either feature individually. These results demonstrate
that asymmetry may be determined by more factors
than just relative stability, and algorithms for predic-
tion of siRNA activity should also account for termi-
nal nucleotide sequence classification in asymmetry
calculations.
Results
Ranking and selection of EGFP-targeting siRNAs
Our ranking algorithm was initially tested on siRNAs
to target the EGFP mRNA. From the cDNA sequence
(Doc. S1), there were 824 possible siRNA sequences,
which were ranked according to the difference between
the algorithm’s predicted likelihood of high and low
activity. For comparison, commercial algorithms
(Dharmacon and Ambion) were also used. These selec-
tion algorithms were chosen because their predictions
are based solely on the characteristics of the siRNA
and not on other factors used in some selection algo-
rithms, such as target mRNA structure, which would
make it difficult to directly compare the accuracy of
our asymmetry-based predictions with predictions
from more detailed selection approaches. The commer-
cial rankings only included sequences predicted to
have high activity, as opposed to the entire range of
possible siRNA sequences. Although this is adequate
for those needing effective siRNA sequences, it does
not provide sufficient data to enable comparison of
the characteristics of high-activity and low-activity
siRNAs. The Dharmacon algorithm ranked the recom-
mended siRNAs, whereas for the Ambion algorithm
there were no distinctions among the top 35 candidate
sequences. Interestingly, there was no overlap between
the lists of recommended sequences provided by the
commercial algorithms. Aggregating the commercial
recommendations with our predictions, we chose 11
sequences to test experimentally that would allow us
to preliminarily compare the relative utility of the
three prediction approaches (Table 1).
Transfection experiments were performed with
human lung carcinoma (H1299)-EGFP cells at vari-
ous siRNA concentrations (Fig. 2). Surprisingly, 81%
of the sequences had some silencing effect as com-
pared with control treatments, with 73% of sequences
showing a > 75% reduction in protein levels at
Fig. 1. Algorithm features for designing highly active siRNAs. From the selected mRNA target, all potential siRNAs were classified
according to their terminal sequence and thermodynamic stability. For the terminal sequence (circles), the 5′-terminal nucleotides, antisense:
sense strand, were used; thermodynamic stability (shaded rectangles) was calculated on the basis of DDG values, using the three terminal
nearest neighbors. All sequences were synthesized to contain UU overhangs on the 3′-ends.
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siRNA concentrations of 50 nM and 100 nM. One
sequence (EGFP 783) showed intermediate silencing
(the difference from other sequences is indicated by
double asterisks), suggesting a gradient, rather than a
step change, in silencing ability between active and
inactive sequences. In general, sequences predicted by
our algorithm to have higher activity showed
increased inhibition of EGFP fluorescence. The rank
order of activities was maintained at lower (5 nM)
and saturating (50 nM and 100 nM) siRNA concentra-
tions. The two sequences chosen on the basis of their
opposing rankings between the two features in our
approach, EGFP 757 (favorable terminal sequence;
unfavorable DDG) and EGFP 783 (unfavorable
terminal sequence; favorable DDG), ultimately showed
activities that correlated with their terminal nucleo-
tide classification rather than their thermodynamic
stability.
To further investigate the hypothesis that terminal
sequence classification was more important than ther-
modynamic stability in predicting siRNA activity,
silencing efficiencies were compared against algorithm
rank, terminal nucleotide rank and DDG values indi-
vidually (Fig. 3). The correlation between activity and
terminal nucleotide rank was better than for thermo-
dynamic stability alone, with the correlation with full
algorithm rank being better than either alone. This
agrees with our prior work showing that terminal
nucleotide classification is generally a more informa-
tive predictor of siRNA activity, but that inclusion of
the thermodynamic calculation provides some addi-
tional complementary information [38].
Table 1. EGFP-targeting siRNA sequences selected for this study, sorted by algorithm rank.
5′ Target
position siRNA sequence
5′-End nucleotides
Thermodynamic
DDG (kcalmol1)
Algorithm
rank Testing rationale
Antisense:
Sense Rank
415 UGUACUCCAGCUUGUGCCC U:G 1 4.2 1 Highest algorithm ranking
416 UUGUACUCCAGCUUGUGCC U:G 1 2.1 17 Highest Dharmacon rank (91)
274 UGCGCUCCUGGACGUAGCC U:G 1 0.8 38 On Ambion list
757 UGGGCAGCGUGCCAUCAUC U:G 1 2.6 177 High end, low DDG
306 CUUGUAGUUGCCGUCGUCC C:G 7 2.9 239 On Ambion list
396 CAGGAUGUUGCCGUCCUCC C:G 7 0.5 389 On Ambion list
126 GAUGAACUUCAGGGUCAGC G:G 10 1.9 418 On Ambion list
711 AUGGCUAAGCUUCUUGUAC A:G 2 3.7 551 Low rank, high Dharmacon (73)
783 CAUCCCGCUCUCCUGGGCA C:U 16 3.1 695 Low end, high DDG
159 GGGCCAGGGCACGGGCAGC G:G 10 2.3 700 On Ambion list
253 CGGGCAUGGCGGACUUGAA C:U 16 5.2 824 Lowest algorithm rank
Fig. 2. Silencing of EGFP by selected siRNAs. H1299 cells expressing EGFP were treated with 5, 50 and 100 nM siRNA for 24 h with LF2K.
Results are normalized to the EGFP fluorescence of control cells treated only with LF2K. siRNA treatments are ordered on the basis of
algorithm predictions (415 = highest predicted activity; 253 = lowest predicted activity). Error bars represent  1 standard deviation; n = 4
(5 nM), n = 5 (50 nM), and n = 3 (100 nM). *Significant difference (P < 0.05) as compared with LF2K-only treatments. **Significant difference
(P < 0.05) as compared with EGFP 783.
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Ranking and selection of PKR-targeting siRNAs
Although our algorithm successfully predicted active
and inactive sequences for EGFP, we wanted to con-
firm similar results for an endogenous protein, the sig-
naling pathway mediator PKR. In addition, through
systematic selection of siRNAs of high, medium and
low nucleotide ranking and siRNAs having high, med-
ium and low relative thermodynamic stabilities
(Table 2), we aimed to further explore the relative
importance of each of these characteristics in predicting
silencing activity. We selected PKR as a model endoge-
nous protein on the basis of our prior work and exper-
tise in silencing this protein [39]. Although PKR is a
double-stranded RNA-responsive protein and is known
to be functionally connected to proteins in the RNAi
pathway [40], the lack of any cytotoxicity across all of
our experiments suggested that it was not initiating any
generalized immune response to the siRNAs that would
confound our specific silencing results.
Transfection experiments were performed with
hepatocellular carcinoma (HepG2) cells at 100 nM
siRNA (Fig. 4). In this case, 55% of sequences
showed a > 50% reduction in PKR protein levels as
compared with control cells. Again, sequences pre-
dicted to have higher activity showed increased
reduction in PKR protein levels. When sorted by
end-nucleotide classification, sequences in the UG
class showed the best silencing activity, on average,
regardless of their thermodynamic stability. Con-
versely, sequences in the low-ranking terminal nucleo-
tide class, CU, did not show significant silencing,
even when they had highly positive DDG values. In
the intermediate category of end sequence (AA),
silencing activity correlated strongly with the calcu-
lated thermodynamic stability, with a favorable value
resulting in significant silencing and an unfavorable
value not. Taken together with our results from the
EGFP experiments, these results support the argu-
ment that terminal sequence classification is a stron-
A B
C D
Fig. 3. Correlation of exogenous gene silencing with each feature of the algorithm. EGFP silencing results are plotted against terminal
nucleotide rank only (A), DDG values only (B), or algorithm rank (C). The squares represent 5 nM siRNA, and the diamonds represent 100 nM
siRNA. For visual clarity, the 50 nM data points were not included in the plots, but they showed the same trend for silencing activity. The
correlation coefficients for each dataset are tabulated (D).
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ger predictor of siRNA activity that relative hybrid-
ization stability.
Our algorithm achieved a better correlation
between rank and siRNA activity than achieved by
either terminal nucleotide or thermodynamic stability
independently (Fig. 5). Although the PKR terminal
nucleotide correlation is less than that achieved from
the EGFP data, the thermodynamic stability and
overall algorithm rank correlation coefficients remain
similar, even with a larger range of possible siRNA
sequences (2352 for PKR versus 824 for EGFP),
showing the algorithm’s fidelity for targets of various
sizes. It is noteworthy that, for both sequences, the
top-ranked sequence, i.e. the one that would have
been chosen for predicting the activity of an siRNA
against a new target, was highly active in silencing
the target, further supporting our hypothesis that
using only two parameters was sufficient for identify-
ing active siRNAs against novel targets.
Discussion
The use of asymmetry is well established as being use-
ful and important for selecting active siRNA
sequences. Multistep workflow protocols for selecting
effective siRNAs have been developed [41,42]. How-
ever, the selection algorithms themselves are based in
part on using relative thermodynamic stability as the
sole factor in determining sequence asymmetry. Other
reported algorithms lack a consensus on the best way
to calculate thermodynamic asymmetry for siRNA
activity prediction [36,43–47]. When the commercially
Table 2. PKR-targeting siRNA sequences selected for this study, sorted by end-sequence ranking, followed by relative thermodynamic
stability.
5′ Target
position siRNA sequence
5′-End nucleotides
Thermodynamic
DDG (kcalmol1) Algorithm rank Testing rationale
Antisense:
Sense Rank
410 UAAUGAAAUCCUUCUGGCC U:G 1 6.3 1 High end, high DDG
193 UCUUUGAUCUACCUUCACC U:G 1 1.9 61 Previously validated
816 UUUAAAAUCCAUGCCAAAC U:G 1 0 230 High end, medium DDG
952 UUGCCAAUGCUUUUACUUC U:G 1 4.2 948 High end, low DDG
336 AAUUCUAUUGAUAAGGCCU A:A 9 5.3 205 Medium end, high DDG
645 AUCUGCUGAGAAGUCACCU A:A 9 0 1154 Medium end, medium DDG
379 AUGCACACUGUUCAUAAUU A:A 9 5.2 1926 Medium end, low DDG
1198 CAAAGAGUUCCAAAGCCAA C:U 16 5.5 1606 Low end, high DDG
640 CUGAGAAGUCACCUUCAGA C:U 16 0 2206 Low end, medium DDG
928 CCGCCUUCUCGUUAUUAUA C:U 16 5.2 2352 Low end, low DDG
Fig. 4. Silencing of PKR by selected siRNAs. HepG2 cells were reverse-transfected with 100 nM siRNA for 48 h with LF2K. Results are
normalized to both total protein level and PKR levels of control cells treated only with LF2K (black). siRNAs were grouped by end-sequence
rank: UG (light gray), AA (striped), and CU (medium gray). Error bars represent  1 standard deviation; n = 3. *Significant difference
(P < 0.05) as compared with LF2K-only treatment.
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available algorithms were utilized for comparison in
this study, there were no overlaps between the
sequences predicted to be highly active by Dharmacon
and those predicted by Ambion, further illustrating the
need for a consensus approach to selecting highly
active siRNAs, including which parameters are most
important/useful for such predictions.
The results described here further illustrate that
accounting only for thermodynamic asymmetry ignores
a more important feature in asymmetry, terminal
nucleotide classification. Although others have identi-
fied terminal nucleotides as factors relevant to siRNA
design (e.g. [35]), our approach of pairing the antisense
and sense termini and weighting each pairing individu-
ally provides a unique and improved classification for
sequences and their activities. Our selection technique
achieves correlation coefficient values of > 0.8, whereas
previously reported algorithms typically achieve corre-
lation coefficients of 0.5–0.7 between algorithm predic-
tions and experimental results [41,48]. As our
approach is focused on the contribution of asymmetry
in the siRNA to its ultimate activity, it was important
to compare our approach with other ways of determin-
ing asymmetry. In calculating thermodynamic asym-
metry, it is common to use one, three or four nearest
neighbors at each end of the siRNA as the basis for
calculation [29,36,48,49]. In our prior work [38], we
showed that, in concert with terminal nucleotide classi-
fication, calculating thermodynamic asymmetry with
three nearest neighbor parameters provided the most
information, whereas one nearest neighbor provided
the most information in the absence of terminal nucle-
otide classification. On the basis of this context, we
compared the correlation of our data with thermody-
namic calculations performed with one, three and four
nearest neighbor parameters (Fig. 6). In all cases, the
correlation of our experimental data was best with
rankings including terminal nucleotide classification
(Table 3). This strongly supports our contention that
all siRNA selection algorithms would be improved by
A B
C D
Fig. 5. Correlation of endogenous gene silencing with each feature of the algorithm. PKR silencing results are plotted against terminal
nucleotide rank only (A), DDG values only (B), or algorithm rank (C). The correlation coefficients for each dataset are tabulated (D).
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the inclusion of our asymmetry approach in place of
their current asymmetry calculation.
Our algorithm, as structured, only ranks sequences
according to the likelihood of them silencing the intended
target. It was our intention in this study to determine
whether the factors that we tested were useful in predict-
ing sequences of high activity. Our ranking approach
does not account for potential off-target effects of the
sequences. For the long-term design of siRNA therapeu-
tics, it is essential that off-target effects be taken into
account as well. That said, it is our belief that beginning
therapeutic design with the most highly active sequence,
which can then be modified, if needed, to improve its
specificity, is a better approach to obtaining a useful ther-
apeutic than beginning with the most highly specific
sequence, which may then need to be modified to
improve its silencing activity against the intended target.
Although our approach is useful for predicting
active (and inactive) siRNAs, we have not yet estab-
lished the causal relationship between the terminal
nucleotide classification and siRNA processing and
activity. Indeed, it is well established that the proper-
ties of the siRNA alone provide only partial
information regarding the likely activity of the siRNA
[14,15,50,51]. However, studies are increasingly
reporting that more active siRNAs and microRNAs
tend to contain specific nucleotides at the 5′-position
of the guide strand [18,33,52], possibly a result of
argonaute 2 binding specificity [30]. We expect that,
going forward, our ongoing work and that of others
will more firmly tie the presence of particular 5′-end
nucleotides on both the guide and passenger strands
with important siRNA–protein interactions that occur
in the pathway to ensure proper siRNA processing.
Experimental procedures
Algorithm design and parameters
Using information from both terminal nucleotide classifi-
cation and thermodynamic stability, we developed a 17-
parameter logistic regression model based on both the 16
possible end-sequence combinations and the relative ther-
modynamic stability (Table 4; additional details in Doc.
S1). The relative stability is calculated from the difference
between the hybridization free energy from the 5′-end of
the antisense strand and the 5′-end of the sense strand,
termed DDG, based on the three terminal nearest neighbor
pairs [38,53] (Fig. 1). DDG calculations were based on
21-nucleotide siRNAs with equivalent UU overhangs on
the end of each strand. This calculation technique, when
coupled with terminal sequence information, was shown
to have the best predictive accuracy when tested on exist-
ing siRNA activity databases [38]. The weighting factors
for each of the 17 parameters were based on fitting the
model to the same siRNA databases [43,44]. From a
cDNA sequence input, the algorithm predicts the proba-
bility that the given sequence will have high, medium or
low activity. By use of the difference between the high
and low probabilities, each siRNA sequence for a given
target was ranked from the highest to the lowest differ-
ence. The cDNA sequences used for EGFP and PKR are
included in Doc. S1, with siRNA target regions high-
lighted. For comparison with other asymmetry approaches
(Fig. 6), asymmetry calculations were also performed with
one and four nearest neighbor parameters. To ensure the
most accurate comparisons across ranking approaches,
sequences with equivalent values were all given the best
possible ranking.
Table 3. The correlation coefficients between EGFP silencing at
100 nM and the four different ranking methods in Fig. 6.
Correlation coefficient (r) 100 nM
Algorithm 0.814
DDG (1 nearest neighbor) 0.539
DDG (3 nearest neighbors) 0.424
DDG (4 nearest neighbors) 0.327
Table 4. Values of the coefficients used as weighting factors for
predicting the probability of siRNAs having high (top third among all
possible sequences) and low (bottom third among all possible
sequences) activity.
Classifier P (high) P (low)
DDG 0.2973 0.1661
U:G 1.8767 0.9852
A:G 0.3737 0.0193
U:C 1.8744 1.3088
U:A 1.7387 1.0301
A:C 0.4764 0.406
U:U 1.5084 1.0877
C:G 0.2463 0.4025
G:C 0.6404 0.3337
A:A 0.2381 0.0810
G:G 0.7873 0.2945
A:U 0.5707 0.3471
C:C 0.3552 0.0987
G:A 1.1939 0.6077
G:U 2.2329 1.3262
C:A 1.1755 0.9055
C:U 2.2846 1.2957
Intercept 0.0498 0.2145
Positive values indicate features that are positively correlated with
high siRNA activity. By application of these weights in our algo-
rithm, siRNAs were ranked by the magnitude of the difference
between the probability of having high activity and the probability
of having low activity. The ‘Intercept’ is applied to all sequences,
and arises from the regression model (Doc. S1).
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Dharmacon ranking information was obtained from
http://dharmacon.com/designcenter/DesignCenterPage (now
available at http://www.thermoscientificbio.com/design-
center/). Potential sequences were determined by entering
the nucleotide sequence directly, removing any GC restric-
tion requirements, and choosing the ‘No BLAST’ option to
provide a direct comparison with the algorithm. Ambion
ranking information was obtained from http://ambion.com/
techlib/misc/siRNA_finder.html (no longer active after
acquisition of Ambion by Life Technologies). A list of
potential siRNAs was generated by entering the nucleotide
sequence; no other selection parameters were required.
Materials
Lipofectamine 2000 (LF2K) was purchased from Invitrogen.
All EGFP and PKR siRNA sequences were 21 nucleotides
long (19 bp plus UU overhangs), and were purchased from
Dharmacon. Opti-Mem (Gibco) was used for preparation of
all transfection solutions. Monoclonal primary antibody
against PKR (Y117) was purchased from Novus Biologicals.
Monoclonal primary antibody against b-actin was pur-
chased from Sigma. Secondary antibodies (anti-rabbit and
anti-mouse) were purchased from ThermoScientific.
Cell culture
H1299 cells constitutively expressing a form of EGFP,
modified to have a 2-h half-life, were generously provided
by J. Kjems (University of Aarhus, Denmark). HepG2 cells
were purchased from the American Type Culture Collec-
tion. Cell culture medium was prepared with DMEM High
Glucose (Invitrogen) supplemented with 10% fetal bovine
serum (Gibco) and 1% penicillin/streptomycin (Gibco). For
the H1299 cells, 1% Geneticin (Gibco) was added to main-
tain EGFP expression. Cells were incubated at 37 °C in
5% CO2, at 100% relative humidity, and subcultured every
4–5 days by trypsinization.
EGFP silencing and fluorescence analysis
H1299-EGFP cells were seeded in 96-well, black-sided,
clear-bottomed plates (Fisher Scientific) at a density of
20 000 cells per well in 0.1 mL of complete medium without
A B
C D
Fig. 6. Correlation of asymmetry calculations with experimental data. Results for 100 nM EGFP silencing plotted against rankings among all
possible siRNA sequences, with DDG calculated with one nearest neighbor (A), three nearest neighbors (B), four nearest neighbors (C), or
our algorithm (three nearest neighbors and terminal nucleotide classification) (D).
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antibiotics. After 24 h, 50-lL solutions of various siRNAs
and LF2K were prepared in Opti-Mem, and allowed to mix
for 30 min prior to their addition to cells at final concentra-
tions of 5–100 nM siRNA and 2.3 lgmL1 LF2K. Cells
were incubated in the transfection solutions at 37 °C in 5%
CO2, at 100% humidity. After 24 h, cells were washed twice
with Dulbecco’s NaCl/Pi (Gibco), and EGFP fluorescence
was quantified with a Gemini EM fluorescent plate reader
(Molecular Devices) at 480-nm excitation and 525-nm emis-
sion. Fluorescence intensity was normalized to control wells
that were treated with transfection reagent but no siRNA.
Cytotoxicity was assessed by microscopy, and was not seen
in any of the treatments (Fig. S1).
PKR silencing and western blotting
For siRNA transfections targeting human PKR in HepG2
cells, reverse transfection was performed. Briefly, 250-lL
solutions of various siRNAs and LF2K were prepared in
Opti-Mem, and allowed to mix for 30 min prior to their
addition to standard six-well tissue culture plates. Freshly
trypsinized HepG2 cells suspended in antibiotic-free medium
were added to the six-well culture plates at a density of
1.5 9 106 cells per well to achieve final concentrations of
100 nM siRNA and 2.3 lgmL1 LF2K. The cells were then
incubated at 37 °C in 5% CO2, at 100% humidity, for 48 h
and collected. PKR levels were measured by western blot
analysis (Fig. S2). The cells were washed twice with cold
NaCl/Pi, and lysed in 200 lL per well of CelLytic M cell
lysis buffer (Sigma) supplemented with protease inhibitor
cocktail (Sigma). The cell lysate was clarified by centrifuga-
tion at 15 000 g for 10 min, and the supernatant was col-
lected. Total protein levels were quantified with the Quick
Start Bradford protein assay (BioRad). Approximately
20 lg of total protein was resolved, with 8% resolving, 5%
stacking SDS/PAGE gels. Proteins were then transferred to
nitrocellulose membranes, and probed with primary and sec-
ondary antibodies. Biotinylated protein ladders (Cell Signal-
ing Technology) were loaded onto one well of each SDS/
PAGE gel, and antibody against biotin was used to detect
the protein ladders on the western blots. Antibody detection
was performed with the SuperSignal West Femto Chemilu-
minescence substrate kit (ThermoScientific), and imaging
was performed with the Molecular Imager ChemiDoc XRS
System (Bio-Rad). Band intensity was first normalized to
actin to control for protein isolation and loading, and the
ratio was then normalized to the ratio for control cells that
received transfection reagent but no siRNA. Cytotoxicity
was assessed by microscopy and CellTiter-Blue assay (Pro-
mega) (Fig. S1), and was not seen in any of the treatments.
Statistical analyses
Multiple comparisons between protein levels across differ-
ent siRNA treatments conditions were performed with one-
way (PKR data) or two-way (EGFP data) ANOVA
followed by Tukey’s HSD post hoc analysis with the
P-value cut-off set at 0.05. Analyses were performed with
either Microsoft Excel or MINITAB.
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